Mosaic and Intronic Mutations in TSC1/TSC2 Explain the Majority of TSC Patients with No Mutation Identified by Conventional Testing

Tuberous sclerosis complex (TSC) is an autosomal dominant tumor suppressor gene syndrome due to germline mutations in either TSC1 or TSC2. 10–15% of TSC individuals have no mutation identified (NMI) after thorough conventional molecular diagnostic assessment. 53 TSC subjects who were NMI were studied using next generation sequencing to search for mutations in these genes. Blood/saliva DNA including parental samples were available from all subjects, and skin tumor biopsy DNA was available from six subjects. We identified mutations in 45 of 53 subjects (85%). Mosaicism was observed in the majority (26 of 45, 58%), and intronic mutations were also unusually common, seen in 18 of 45 subjects (40%). Seventeen (38%) mutations were seen at an allele frequency < 5%, five at an allele frequency < 1%, and two were identified in skin tumor biopsies only, and were not seen at appreciable frequency in blood or saliva DNA. These findings illuminate the extent of mosaicism in TSC, indicate the importance of full gene coverage and next generation sequencing for mutation detection, show that analysis of TSC-related tumors can increase the mutation detection rate, indicate that it is not likely that a third TSC gene exists, and enable provision of genetic counseling to the substantial population of TSC individuals who are currently NMI.

[1]  E. Thiele,et al.  Tuberous Sclerosis Complex , 2019, Harper's Textbook of Pediatric Dermatology.

[2]  R. Nussbaum,et al.  A shower of second hit events as the cause of multifocal renal cell carcinoma in tuberous sclerosis complex. , 2015, Human molecular genetics.

[3]  A. V. D. van den Ouweland,et al.  Targeted Next Generation Sequencing reveals previously unidentified TSC1 and TSC2 mutations , 2015, BMC Medical Genetics.

[4]  E. Roach,et al.  Tuberous sclerosis complex. , 2015, Handbook of clinical neurology.

[5]  E. Thiele,et al.  Tuberous sclerosis complex without tubers and subependymal nodules: a phenotype–genotype study , 2014, Clinical genetics.

[6]  D. Kwiatkowski,et al.  Sun exposure causes somatic second-hit mutations and angiofibroma development in tuberous sclerosis complex. , 2014, Human molecular genetics.

[7]  Hope Northrup,et al.  Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference. , 2013, Pediatric neurology.

[8]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[9]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[10]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[11]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[12]  B. Taillon,et al.  Ultra deep sequencing detects a low rate of mosaic mutations in tuberous sclerosis complex , 2010, Human Genetics.

[13]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[14]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[15]  S. Camposano,et al.  Distinct clinical characteristics of Tuberous Sclerosis Complex patients with no mutation identified , 2009, Annals of human genetics.

[16]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[17]  D. Evans,et al.  Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification , 2007, Journal of Medical Genetics.

[18]  J. Wheless,et al.  Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States , 2007, Genetics in Medicine.

[19]  R. Lazarus,et al.  Identification of 54 large deletions/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations , 2007, Human Genetics.

[20]  Chih-ping Chen,et al.  Molecular and clinical analyses of 84 patients with tuberous sclerosis complex , 2006, BMC Medical Genetics.

[21]  J. Chae,et al.  Mutational analysis of TSC1 and TSC2 in Korean patients with tuberous sclerosis complex , 2006, Brain and Development.

[22]  M. Schwartz,et al.  Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long‐range PCR sequencing, and report of 28 novel mutations , 2005, Human mutation.

[23]  A. Ouweland,et al.  Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype – phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex , 2005, European Journal of Human Genetics.

[24]  A. K. Shukla,et al.  Mutation and polymorphism analysis of TSC1 and TSC2 genes in Indian patients with tuberous sclerosis complex , 2005, Acta neurologica Scandinavica.

[25]  D. Kwiatkowski,et al.  Somatic mosaicism is rare in unaffected parents of patients with sporadic tuberous sclerosis , 2004, Journal of Medical Genetics.

[26]  J. Sampson.  TSC1 and TSC2: genes that are mutated in the human genetic disorder tuberous sclerosis. , 2003, Biochemical Society transactions.

[27]  Siân Jones,et al.  Characterizing mutations in samples with low‐level mosaicism by collection and analysis of DHPLC fractionated heteroduplexes , 2003, Human mutation.

[28]  L. Kluwe,et al.  Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas , 2003, Journal of medical genetics.

[29]  B. Anlar,et al.  Mutation analysis of TSC2 gene in 33 Turkish familial cases with tuberous sclerosis. , 2003, The Turkish journal of pediatrics.

[30]  Janet M. Young,et al.  Nonsense-mediated RNA decay in the TSC1 gene suggests a useful tool pre- and post-positional cloning , 2002, Human Genetics.

[31]  P. Green,et al.  Unusual deep intronic mutations in the COL4A5 gene cause X linked Alport syndrome , 2002, Human Genetics.

[32]  A. Jauch,et al.  TSC1 and TSC2 mutations in tuberous sclerosis, the associated phenotypes and a model to explain observed TSC1/TSC2 frequency ratios , 2002, European Journal of Pediatrics.

[33]  J. A. Bishop,et al.  A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees. , 2001, Human molecular genetics.

[34]  S. Henikoff,et al.  Predicting deleterious amino acid substitutions. , 2001, Genome research.

[35]  J. Cheadle,et al.  Low level mosaicism detectable by DHPLC but not by direct sequencing , 2001, Human mutation.

[36]  D. Kwiatkowski,et al.  Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. , 2001, American journal of human genetics.

[37]  K. Mayer,et al.  Three novel types of splicing aberrations in the tuberous sclerosis TSC2 gene caused by mutations apart from splice consensus sequences. , 2000, Biochimica et biophysica acta.

[38]  K. Yoshikawa,et al.  Analysis of all exons of TSC1 and TSC2 genes for germline mutations in Japanese patients with tuberous sclerosis: report of 10 mutations. , 2000, American journal of medical genetics.

[39]  D. Valle,et al.  Online Mendelian Inheritance In Man (OMIM) , 2000, Human mutation.

[40]  Janine Lewis,et al.  Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis , 1999, Human mutation.

[41]  K. Mayer,et al.  Mutation screening of the entire coding regions of the TSC1 and the TSC2 gene with the protein truncation test (PTT) identifies frequent splicing defects , 1999, Human mutation.

[42]  S. Verhoef,et al.  High rate of mosaicism in tuberous sclerosis complex. , 1999, American journal of human genetics.

[43]  J. Maynard,et al.  Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis. , 1999, American journal of human genetics.

[44]  H. Northrup,et al.  Germ-line mosaicism in tuberous sclerosis: how common? , 1999, American journal of human genetics.

[45]  S. Verhoef,et al.  Mutational spectrum of the TSC1 gene in a cohort of 225 tuberous sclerosis complex patients: no evidence for genotype-phenotype correlation , 1999, Journal of medical genetics.

[46]  D. Kwiatkowski,et al.  Mosaicism in tuberous sclerosis as a potential cause of the failure of molecular diagnosis. , 1999, The New England journal of medicine.

[47]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[48]  D. Evans,et al.  Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations. , 1998, Journal of medical genetics.

[49]  Janet M. Young,et al.  A mutation screen of the TSC1 gene reveals 26 protein truncating mutations and 1 splice site mutation in a panel of 79 tuberous sclerosis patients , 1998, Annals of human genetics.

[50]  K. Volcik,et al.  Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients. , 1998, American journal of human genetics.

[51]  A. Green,et al.  Female germline mosaicism in tuberous sclerosis confirmed by molecular genetic analysis. , 1997, Human molecular genetics.

[52]  E. Haan,et al.  Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene. , 1997, American journal of human genetics.

[53]  S Povey,et al.  Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. , 1997, Science.

[54]  A. Ouweland,et al.  Somatic mosaicism and clinical variation in tuberous sclerosis complex , 1995, The Lancet.

[55]  S. Thomas,et al.  Identification and characterization of the tuberous sclerosis gene on chromosome 16 , 1993, Cell.

[56]  J B Stephenson,et al.  Genetic aspects of tuberous sclerosis in the west of Scotland. , 1989, Journal of medical genetics.